Cargando…

Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU

BACKGROUND: Mechanisms triggering the pathogenesis of chronic spontaneous urticaria (CSU) have been identified as type I autoallergic (which is associated with IgE antibodies against autoantigens) and type IIb autoimmune (which is driven by autoantibodies to FceR1 and/or IgE). OBJECTIVE: Our aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Sella, Juliana A., Ferriani, Mariana P.L., Melo, Janaina M.L., Trevisan Neto, Orlando, Zanetti, Maria Eduarda T., Cordeiro, Daniel L., Lemos, José E., Barros, Sebastião A., Aragon, Davi C., Arruda, L. Karla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509944/
https://www.ncbi.nlm.nih.gov/pubmed/37781653
http://dx.doi.org/10.1016/j.jacig.2023.100159
_version_ 1785107862720086016
author Sella, Juliana A.
Ferriani, Mariana P.L.
Melo, Janaina M.L.
Trevisan Neto, Orlando
Zanetti, Maria Eduarda T.
Cordeiro, Daniel L.
Lemos, José E.
Barros, Sebastião A.
Aragon, Davi C.
Arruda, L. Karla
author_facet Sella, Juliana A.
Ferriani, Mariana P.L.
Melo, Janaina M.L.
Trevisan Neto, Orlando
Zanetti, Maria Eduarda T.
Cordeiro, Daniel L.
Lemos, José E.
Barros, Sebastião A.
Aragon, Davi C.
Arruda, L. Karla
author_sort Sella, Juliana A.
collection PubMed
description BACKGROUND: Mechanisms triggering the pathogenesis of chronic spontaneous urticaria (CSU) have been identified as type I autoallergic (which is associated with IgE antibodies against autoantigens) and type IIb autoimmune (which is driven by autoantibodies to FceR1 and/or IgE). OBJECTIVE: Our aim was to define presumptive endotypes in patients with CSU by using tests amenable to use in routine clinical practice. METHODS: A retrospective analysis of the medical records of 394 patients with CSU with or without chronic inducible urticaria or angioedema was performed. Patients were assigned to 1 of 4 groups as follows: (1) type I endotype of CSU, if they presented at least 1 of the following: allergic disease, total IgE level of at least 40UI/mL, and positive result of skin tests to inhalant allergen(s), (2) type IIb endotype of CSU, if they presented at least 1 of following: autoimmune disease, low total IgE level less than 40 IU/mL, positive autologous serum skin test result, positive for antinuclear antibodies in a titer of at least 1:160, and elevated level of anti–thyroid peroxidase, (3) overlap of type I/type IIb endotypes of CSU, if they presented with at least 1 marker of both type I and type IIb, and (4) non–type I/type IIb endotype of CSU, if they presented with none of the markers of type I or type IIb. RESULTS: The mean age at onset of symptoms was 34 years; 82.2% of those with CSU were female, and angioedema and chronic inducible urticaria were found in 74.8% and 31.9% of patients, respectively. Of the patients with CSU, 38% presented with the type I endotype and 51% presented with type I/type IIb overlap, whereas 9% presented with the type IIb endotype and 2% presented with the non–type I/type IIb endotype. Eosinopenia was associated with type IIb and type I/type IIb overlap as opposed to the type I and non–type I/type IIb endotypes (P = .02). CONCLUSIONS: Most patients with CSU presented with features of the type 1 (autoallergic) endotype, whether associated with type IIb (autoimmune) endotype or not.
format Online
Article
Text
id pubmed-10509944
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105099442023-09-29 Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU Sella, Juliana A. Ferriani, Mariana P.L. Melo, Janaina M.L. Trevisan Neto, Orlando Zanetti, Maria Eduarda T. Cordeiro, Daniel L. Lemos, José E. Barros, Sebastião A. Aragon, Davi C. Arruda, L. Karla J Allergy Clin Immunol Glob Brief Report BACKGROUND: Mechanisms triggering the pathogenesis of chronic spontaneous urticaria (CSU) have been identified as type I autoallergic (which is associated with IgE antibodies against autoantigens) and type IIb autoimmune (which is driven by autoantibodies to FceR1 and/or IgE). OBJECTIVE: Our aim was to define presumptive endotypes in patients with CSU by using tests amenable to use in routine clinical practice. METHODS: A retrospective analysis of the medical records of 394 patients with CSU with or without chronic inducible urticaria or angioedema was performed. Patients were assigned to 1 of 4 groups as follows: (1) type I endotype of CSU, if they presented at least 1 of the following: allergic disease, total IgE level of at least 40UI/mL, and positive result of skin tests to inhalant allergen(s), (2) type IIb endotype of CSU, if they presented at least 1 of following: autoimmune disease, low total IgE level less than 40 IU/mL, positive autologous serum skin test result, positive for antinuclear antibodies in a titer of at least 1:160, and elevated level of anti–thyroid peroxidase, (3) overlap of type I/type IIb endotypes of CSU, if they presented with at least 1 marker of both type I and type IIb, and (4) non–type I/type IIb endotype of CSU, if they presented with none of the markers of type I or type IIb. RESULTS: The mean age at onset of symptoms was 34 years; 82.2% of those with CSU were female, and angioedema and chronic inducible urticaria were found in 74.8% and 31.9% of patients, respectively. Of the patients with CSU, 38% presented with the type I endotype and 51% presented with type I/type IIb overlap, whereas 9% presented with the type IIb endotype and 2% presented with the non–type I/type IIb endotype. Eosinopenia was associated with type IIb and type I/type IIb overlap as opposed to the type I and non–type I/type IIb endotypes (P = .02). CONCLUSIONS: Most patients with CSU presented with features of the type 1 (autoallergic) endotype, whether associated with type IIb (autoimmune) endotype or not. Elsevier 2023-07-27 /pmc/articles/PMC10509944/ /pubmed/37781653 http://dx.doi.org/10.1016/j.jacig.2023.100159 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Brief Report
Sella, Juliana A.
Ferriani, Mariana P.L.
Melo, Janaina M.L.
Trevisan Neto, Orlando
Zanetti, Maria Eduarda T.
Cordeiro, Daniel L.
Lemos, José E.
Barros, Sebastião A.
Aragon, Davi C.
Arruda, L. Karla
Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
title Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
title_full Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
title_fullStr Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
title_full_unstemmed Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
title_short Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
title_sort type i and type iib autoimmune chronic spontaneous urticaria: using common clinical tools for endotyping patients with csu
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509944/
https://www.ncbi.nlm.nih.gov/pubmed/37781653
http://dx.doi.org/10.1016/j.jacig.2023.100159
work_keys_str_mv AT sellajulianaa typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu
AT ferrianimarianapl typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu
AT melojanainaml typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu
AT trevisannetoorlando typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu
AT zanettimariaeduardat typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu
AT cordeirodaniell typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu
AT lemosjosee typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu
AT barrossebastiaoa typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu
AT aragondavic typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu
AT arrudalkarla typeiandtypeiibautoimmunechronicspontaneousurticariausingcommonclinicaltoolsforendotypingpatientswithcsu